Sacubitril/valsartan: beyond natriuretic peptides
Author:
Publisher
BMJ
Subject
Cardiology and Cardiovascular Medicine
Reference51 articles.
1. Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond;Singh;Vasc Health Risk Manag,2015
2. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure;Cohn;N Engl J Med,2001
3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014
4. Natriuretic peptides;Daniels;J Am Coll Cardiol,2007
5. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin;Kalra;Cardiovasc Res,2001
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system;Frontiers in Pharmacology;2024-08-13
2. Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure;Current Problems in Cardiology;2024-04
3. Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model;Frontiers in Cardiovascular Medicine;2024-02-14
4. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF;ESC Heart Failure;2024-01-15
5. Efficacy of Sacubitril Valsartan sodium tablets in patients with heart failure combined with pulmonary infection and long-term recurrence rate;American Journal of Translational Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3